StockNews.AI
KVUE
StockNews.AI
208 days

Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025

1. Kenvue Inc. will announce Q4 and full year 2024 results on February 6, 2025. 2. A conference call will provide financial insights at 8:00 a.m. ET. 3. Kenvue is a leading consumer health company with iconic brands. 4. The webcast will be available live and for replay after the call. 5. Financial performance impacts KVUE's market perception and stock value.

Earnings
+0.1%Current Return
VS
+0.33%S&P 500
$20.7501/23 06:56 AM EDTEvent Start
$20.7701/24 01:26 PM EDTLatest Updated
3m saved
Insight
Article

FAQ

Why Neutral?

Upcoming financial results can sway investor sentiment, but outcomes are uncertain.

How important is it?

Earnings announcements typically provide critical information affecting stock prices.

Why Short Term?

Results will directly influence price in the immediate trading period.

Related Companies

KVUE
SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) will announce its fourth quarter and full year 2024 financial results before market open on February 6, 2025. The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial results. The conference call can be accessed by dialing 877-407-8835 from the U.S. or +1 201-689-8779 from international locations. A live webcast of the conference call can also be accessed at investors.kenvue.com, with a replay made available after the live event. About Kenvue Kenvue Inc. is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers’ hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.

Related News